TC-1 Tumor-bearing Mice Injected with DNA Encoding NKG2D-Fc-IL2 Exhibit an Increased Number of Luciferase-expressing E7-specific CD8+ T Cells at the Tumor Site. Here, CD8A is linked to neoplasm.